Skip to content
Search

Latest Stories

PDA pledges 'full support' to Rowlands pharmacists

The Pharmacists’ Defence Association (PDA) has pledged full support to its members at Rowlands pharmacies with appropriate help to protect their legal and contractual rights.

This follows Rowlands’ announcement on Monday (October 5) to cut pharmacy opening hours by an average of ten hours per week early in 2021. Pharmacists at Rowlands see the latest move of the company as potential job cuts.


The PDA also assured them of working "appropriately with the company to find agreed solutions with our members whenever possible.”

“This is the latest major closure announcement from a pharmacy multiple in the community sector following significant cuts to government funding for community pharmacy over recent years and sadly it may not be the last,” PDA noted.

The association added: “Our immediate concerns are about the livelihoods and wellbeing of our members who may find themselves in one of the affected Rowlands pharmacies.

“Many employees will have statutory protections regarding their contracts, job security and/or redundancy entitlement; however, we urge any affected PDA members to contact us so that we can provide advice on their individual position. The PDA team includes experts in employment law so we can help with many aspects of such a change.”

PDA has urged the employer to invest in adequate staffing and other resources for the long-term benefit of all.

Mark Pitt, director of defence at PDA, said: “Our members at Rowlands will be understandably concerned about this announcement.  We are already hearing from those who expect to be directly affected and others who have worries about their pharmacy.  Once more details are known we will be able to help individuals with any specific concerns.

“Pharmacists can be reassured that the PDA will help members protect their employment rights and ensure they are treated fairly.  Members should contact us for advice if they are impacted by these proposed changes.”

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less